4//SEC Filing
Zakrzewski Joseph S 4
Accession 0000899243-22-012992
CIK 0001880438other
Filed
Mar 30, 8:00 PM ET
Accepted
Mar 31, 8:15 PM ET
Size
7.0 KB
Accession
0000899243-22-012992
Insider Transaction Report
Form 4
Zakrzewski Joseph S
Director
Transactions
- Conversion
Common Stock
2022-03-29+98,199→ 98,199 total - Conversion
Series A Convertible Preferred Stock
2022-03-29−98,199→ 0 total→ Common Stock (98,199 underlying)
Footnotes (1)
- [F1]Each share of Preferred Stock automatically converts on a one-for-one basis into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration. The shares of Preferred Stock have no expiration date.
Documents
Issuer
AN2 Therapeutics, Inc.
CIK 0001880438
Entity typeother
Related Parties
1- filerCIK 0001331852
Filing Metadata
- Form type
- 4
- Filed
- Mar 30, 8:00 PM ET
- Accepted
- Mar 31, 8:15 PM ET
- Size
- 7.0 KB